reports
Codexis to Report First Quarter 2024 Financial Results on May 2
Codexis to Report First Quarter 2024 Financial Results on May 2 REDWOOD CITY, Calif., April 18, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that it will report its financial results for the first quarter of 2024 on Thursday, May 2, 2024, following the close of market. Codexis management will host a conference call and webcast at 4:30 pm Eastern Time to discuss the Company’s financial results and provide a business update. Participants may access the live webcast on the , where it will be archived for 90 days. The live call ...
WW International, Inc. Schedules First Quarter 2024 Earnings Conferenc...
WW International, Inc. Schedules First Quarter 2024 Earnings Conference Call NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) will release its results for the first quarter 2024 after market close on Thursday, May 2, 2024. WeightWatchers will host a conference call at 5:00 p.m. ET the same day. During the conference call, Sima Sistani, Chief Executive Officer, and Heather Stark, Chief Financial Officer, will discuss the first quarter 2024 results and answer questions from the investment community. The live webcas...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXL...
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy 46.2% of patients demonstrated a 1- or 2-step improvement in the Diabetic Retinopathy Severity Scale (DRSS) at 40 weeks in the AXPAXLI arm, compared to 0% in the control arm No patients in the AXPAXLI group experienced worsening in DRSS compared to 12.5% in the control arm at 40 weeks AXPAXLI was generally well tolerated with no inflammation observed Ocular intends to present the Phase 1 HELIOS study at an upcoming meeting BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeut...
EQS-News: Sartorius: Ergebnisse des 1. Quartals im Rahmen der Erwartun...
EQS-News: SARTORIUS AG / Schlagwort(e): Quartalsergebnis Sartorius: Ergebnisse des 1. Quartals im Rahmen der Erwartungen; Wiederholgeschäft mit deutlichem Auftragswachstum; Nachfrage aus China weiter schwach; Ausblick für Gesamtjahr bestätigt (News mit Zusatzmaterial) 18.04.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Göttingen, 18. April 2024 Sartorius: Ergebnisse des 1. Quartals im Rahmen der Erwartungen; Wiederholgeschäft mit deutlichem Auftragswachstum; Nachfrage aus China weiter schwach; Ausblick für Gesamtjahr ...
EQS-News: Sartorius: First quarter results in line with expectations; ...
EQS-News: SARTORIUS AG / Key word(s): Quarter Results Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed (news with additional features) 18.04.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Göttingen, April 18, 2024 Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed Inventory reduc...
Businesses Increasingly Searching for AI Influencers and Trademark Att...
Businesses Increasingly Searching for AI Influencers and Trademark Attorneys, According to Fiverr's Latest Business Trends Index Fiverr's 9th Business Trends Index reveals that businesses are looking for solutions to elevate organizational performance and productivity NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is changing how the world works together, today released its Among the millions of inquiries on Fiverr’s marketplace, these digital services saw the largest increase in demand over the last six months. Taking advantage of ...
- Wedbush Research
2454 MEDIATEK INC.
VMW VMWARE INC. CLASS A
ADS ADIDAS AG
WDC WESTERN DIGITAL CORPORATION
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
INTC INTEL CORPORATION
BIIB BIOGEN INC.
ARDX ARDELYX INC
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
HPE HEWLETT PACKARD ENTERPRISE CO.
SNBR SLEEP NUMBER CORPORATION
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
IBM INTERNATIONAL BUSINESS MACHINES CORPORATION
APLS APELLIS PHARMACEUTICALS
AVGO BROADCOM INC.
DELL DELL TECHNOLOGIES INC CLASS C
SMCI SUPER MICRO COMPUTER
TVTX INC.
MRVL TRAVERE THERAPEUTICS INC
STX MARVELL TECHNOLOGY INC
DBD SEAGATE TECHNOLOGY HLDGS PLC
DIEBOLD NIXDORF INC
- Laura Chico
Mercer International Inc. Announces Conference Call for First Quarter ...
Mercer International Inc. Announces Conference Call for First Quarter 2024 Results NEW YORK, April 16, 2024 (GLOBE NEWSWIRE) -- Mercer International (NASDAQ: MERC) will release its first quarter results for the period ending March 31, 2024 on Thursday, May 9, 2024, after the close of the market. Juan Carlos Bueno, President and Chief Executive Officer and Richard Short, Chief Financial Officer and Secretary, will be hosting a conference call on Friday, May 10, 2024, at 10:00 am ET to discuss the results. The conference call will be available to interested parties live over the Internet t...
ibex’s Christy O’Connor Named Among Top 50 Chief Legal Officers
ibex’s Christy O’Connor Named Among Top 50 Chief Legal Officers WASHINGTON, April 16, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced that Christy O’Connor has been named among the by Women We Admire. O’Connor has served as Chief Legal Officer of ibex since March 2018, where she has been instrumental in the company’s success, from its initial public offering in 2020 to its cutting-edge AI-enabled customer engagement solutions that help organizations acquire, enga...
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key ...
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders Nadia K. Waheed, MD, MPH, Appointed Chief Medical Officer; Peter K. Kaiser, MD, to Become Chief Development Officer; Andrea Gibson, PhD, Named Vice President, Medical Collaborations; and Namrata Saroj, OD, to Become Development Strategy Consultant Dr. Waheed’s strong industry track record as a CMO and broad expertise in wet AMD and diabetic retinopathy support advancing the Phase 3 AXPAXLI™ program Dr. Kaiser’s vast leadership experience in numerous pivotal trials of approved wet AMD products enhances Oc...
- Wedbush Research
PMT PENNYMAC MORTGAGE INVESTMENT TRUST
WDC WESTERN DIGITAL CORPORATION
UMH UMH PROPERTIES INC.
SIMON SILICON MOTION TECHNOLOGY CORPORATION SPONSORED ADR
RWT REDWOOD TRUST INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
QCOM QUALCOMM INC
PSTG PURE STORAGE INC. CLASS A
NVDA NVIDIA CORPORATION
NTAP NETAPP INC.
NRZ NEW RESIDENTIAL INVESTMENT CORP.
MXL MAXLINEAR INC
MU MICRON TECHNOLOGY INC.
MFA MFA FINANCIAL INC.
INTC INTEL CORPORATION
GOOGL ALPHABET INC. CLASS A
AXTI AXT INC.
ABR ARBOR REALTY TRUST INC.
WD WALKER & DUNLOP INC.
SWKS SKYWORKS SOLUTIONS INC.
2330 TAIWAN SEMICONDUCTOR MANUFACTURING CO. LTD.
2303 UNITED MICROELECTRONICS CORP.
AMZN AMAZON.COM INC.
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
MSFT MICROSOFT CORPORATION
AVGO BROADCOM INC.
RC READY CAPITAL CORPORATION
COOP MR. COOPER GROUP INC.
SMCI SUPER MICRO COMPUTER
PFSI INC.
RKT PENNYMAC FINANCIAL SERVICES INC.
GHLD ROCKET COMPANIES
MRVL GUILD HOLDINGS
STX MARVELL TECHNOLOGY INC
UWMC SEAGATE TECHNOLOGY HLDGS PLC
GFS UWM HLDGS CORP
EWTX GLOBALFOUNDRIES INC
CAVA EDGEWISE THERAPEUTICS INC
CAVA GROUP INC
- Brian Violino
- Henry Coffey
- Jay McCanless
UMH UMH PROPERTIES INC.
RWT REDWOOD TRUST INC.
NRZ NEW RESIDENTIAL INVESTMENT CORP.
MFA MFA FINANCIAL INC.
ABR ARBOR REALTY TRUST INC.
WD WALKER & DUNLOP INC.
RC READY CAPITAL CORPORATION
COOP MR. COOPER GROUP INC.
PFSI PENNYMAC FINANCIAL SERVICES INC.
RKT ROCKET COMPANIES
GHLD GUILD HOLDINGS
UWMC UWM HLDGS CORP
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expan...
ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC Initiated multiple Phase 1b expansion cohorts to determine the RP2D of ORIC-114 in NSCLC patients with EGFR exon 20, HER2 exon 20, or EGFR atypical mutations Additionally, the company initiated an extension cohort to evaluate ORIC-114 for the treatment of patients with first-line, treatment-naïve EGFR exon 20 NSCLC Expect to report updated Phase 1b data in the first half of 2025 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, April 15, 2024 (G...
Sprout Social Announces CEO Succession Plan
Sprout Social Announces CEO Succession Plan President Ryan Barretto to be promoted to Chief Executive Officer, effective October 1, 2024; CEO Justyn Howard to transition to Executive Chair CHICAGO, April 15, 2024 (GLOBE NEWSWIRE) -- , Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced that President Ryan Barretto will become Sprout Social’s CEO, effective October 1, 2024. Co-Founder and current CEO Justyn Howard will step into the role of Executive Chair. Barretto joined Sprout Social in 201...
Fiverr to Release First Quarter 2024 Results on May 9, 2024
Fiverr to Release First Quarter 2024 Results on May 9, 2024 NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Fiverr International Ltd. (NYSE: FVRR), the company that is changing how the world works together, today announced it will release first quarter financial results for the period ended March 31, 2024, before the market opens on Thursday, May 9, 2024. On that day management will hold a conference call and webcast at 8:30 a.m. ET to discuss the Company’s business and financial results. Prior to its conference call, Fiverr will issue a press release and post a shareholder letter to its web...
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of Defe...
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin) BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced DefenCath® (taurolidine and heparin) catheter lock solution (CLS) is now commercially available for U.S. inpatient use. DefenCath (taurolidine and heparin) is approved by the U.S. Food and Drug Administration (FDA) to reduce the incidence of catheter-related blo...
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes Pre...
Ocular Therapeutix™ Executive Chairman Pravin U. Dugel, MD Becomes President and CEO Antony Mattessich is Stepping Down as President and CEO BEDFORD, Mass., April 15, 2024 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL) (“Ocular”), a biopharmaceutical company committed to enhancing people’s vision and quality of life through the development and commercialization of innovative therapies for wet age-related macular degeneration (wet AMD), diabetic retinopathy, and other diseases and conditions of the eye, today announced that Executive Chairman, Pravin U. Dugel, MD, is assuming t...
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
PSTG PURE STORAGE INC. CLASS A
MDWD MEDIWOUND
LE LANDS' END INC.
HUBS HUBSPOT INC.
ARN ARNOLD GEORG AG
ANAB ANAPTYSBIO INC.
LILA LIBERTY LATIN AMERICA A
CRNX CRINETICS PHARMACEUTICALS
IIIV I3 VERTICALS
EVER EVERQUOTE
BDCO BLUE DOLPHIN ENERGY CO.
ABEO ABEO SA
LYFT LYFT
AEYE AUDIOEYE INC
CRMD CORMEDIX INC.
BDTX BLACK DIAMOND THERAPEUTICS
NRIX NURIX THERAPEUTICS
VITL VITAL FARMS
ALXO ALX ONCOLOGY HOLDINGS
TCRX TSCAN THERAPEUTICS INC
VERA VERA THERAPEUTICS INC
RXST RXSIGHT INC
MAX MEDIAALPHA INC
KRT KARAT PACKAGING INC
SERA SERA PROGNOSTICS INC
ELVN ONTO INNOVATION INC.
IZM IMARA INC
AVGD ICZOOM GROUP INC
ANG AV-GAD HLDGS LTD
EGIO ANGLOGOLD ASHANTI LIMITED
QTTB EDGIO INC.
PROP Q32 BIO INC
AKA PRAIRIE OPERATING CO.
IDR AKA BRANDS HOLDING CORP
1225 IDAHO STRATEGIC RESOURCES INC
AFRISTRAT INV HLDGS LTD
- David Carlson
- David Nierengarten
- Dennis Pak
- Laura Chico
- Martin Fan
- Ritika Das
- Robert Driscoll
- Sam Ravina
XENE XENON PHARMACEUTICALS INC
VRTX VERTEX PHARMACEUTICALS INCORPORATED
SRPT SAREPTA THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
SAGE SAGE THERAPEUTICS INC.
RGNX REGENXBIO INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MNKD MANNKIND CORP.
LL LUMBER LIQUIDATORS HOLDINGS INC.
KURA KURA ONCOLOGY INC.
HD HOME DEPOT INC.
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
TSC TRISTATE CAPITAL HOLDINGS INC
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
NTLA INTELLIA THERAPEUTICS INC.
PK PARK HOTELS & RESORTS INC.
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
OVID OVID THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
VRNA VERONA PHARMA ADS
SE SEA ADS
AMD ADVANCED MICRO DEVICES INC.
APLS APELLIS PHARMACEUTICALS
UBX UNITY BIOTECHNOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
AX AXOS FINANCIAL INC.
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
IMUX IMMUNIC INC
GOSS GOSSAMER BIO
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
APRE APREA THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
RVMD REVOLUTION MEDICINES
PASG PASSAGE BIO
ACET ADICET BIO INC
ASO ACADEMY SPORTS AND OUTDOORS
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
BEAM BEAM THERAPEUTICS
GBIO GENERATION BIO
PRAX PRAXIS PRECISION MEDICINES
COGT COGENT BIOSCIENCES INC
VOR VOR BIOPHARMA
NUVB NUVATION BIO INC (A)
CGEM CULLINAN ONCOLOGY INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
SBTX SILVERBACK THERAPEUTICS
TNGX TANGO THERAPEUTICS
LBPH INC
IKNA LONGBOARD PHARMACEUTICALS
TCRX IKENA ONCOLOGY INC
VERA TSCAN THERAPEUTICS INC
HOWL VERA THERAPEUTICS INC
GLUE WEREWOLF THERAPEUTICS INC
AVTE MONTE ROSA THERAPEUTICS INC
CMPX AEROVATE THERAPEUTICS INC
GMTX COMPASS THERAPEUTICS
JANX GEMINI THERAPEUTICS INC
VIGL JANUX THERAPEUTICS INC
MLTX VIGIL NEUROSCIENCE INC
TYRA MOONLAKE IMMUNOTHERAPEUTICS
PEPG TYRA BIOSCIENCES INC
HR PEPGEN INC
EWTX HEALTHCARE TRUST OF AMERICA INC.
PRME EDGEWISE THERAPEUTICS INC
OCS PRIME MEDICINE INC
APGE OCULIS HOLDING AG
DNTH APOGEE THERAPEUTICS INC
DIANTHUS THERAPEUTICS INC
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.